By comparing the ability of CD20 and EGFR CAR T cells to increase intracellular Ca2+ (Ca2+)i during interaction with their respective targets - B lymphoma and tumor pancreatic cell lines - we reported that EGFR CAR T cells presented fewer responses than CD20 CAR T cells. The gene discussed is EGFR; the disease is neoplasm.